Global Bone Regeneration Material Market Size, Share and Trends Analysis Report, By Product Type (Ceramic-based, Polymer-based, Growth Factor-based, Cell-based, Others), By Application (Orthopedic Surgery, Bone Trauma, Dental Surgery, Others), Forecast (2022-2028)

The global bone regeneration material market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The increase in degenerative joint diseases across the globe has created demand for bone regeneration materials which in turn driving the global bone regeneration material market. Sevral reports regarding degenerative joint disease indicate that 9.6% of men and 18.0% of women over the age of 60 have symptomatic osteoarthritis. According to the expert opinion presented in the EULAR committee report, radiographic evidence of knee osteoarthritis in men and women over the age of 65 is found in 30.0% of the population.

 

The increase in the number of orthopedic surgeries is also encouraging the market. According to the American Academy of Orthopedic Surgeons, approximately 129,000 total knee arthroplasty surgeries were performed in the US in 1990, and the number increased to more than 600,000 in 2010. AAOS is indicated that 3 million TKA procedures performed will be made in 2030 in the US only. In addition, spinal surgery is becoming increasingly popular, and approximately 432,000 spinal fusions are performed in the US each year. Bone grafting and replacement are widely used in the surgery mentioned above. It is likely to boost the bone regeneration transplant market.

 

The introduction of orthopedic products by key players is expected to further the growth of the orthopedic market. For instance, in May 2020, Orthocell Ltd completed a 510 (k) permit from the US FDA to market its CelGro product which is used in the reconstruction of dentures and soft tissues. The company will launch the product in the US market after receiving approval from US FDA. The company focuses on advertising and building a network of key vision leaders across the US It will help the company to promote and place its product in the US market.

 

In 2019, Biogennix LLC, an osteobiologics company that specializes in bone marrow transplants, obtained US FDA 510 (k) Agilon approval, a new collagen-enhanced bone graft. The company is made the product available for sale in the US market. With the launch, the company is expanding its product portfolio and is facing increasing demand from the US market.

 

Market Coverage

 

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

• Competitive Landscape-B&B Dental, BioComp, Ethoss Regeneration Ltd., NovaBone, and Sunstar Americas Inc., among others.

 

Key questions addressed by the report

 

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Bone Regeneration Material Market Report by Segment

 

By Product Type

• Ceramic-based
• Polymer-based
• Growth Factor-based
• Cell-based
• Others

By Application

• Orthopedic Surgery
• Bone Trauma
• Dental Surgery
• Others

 

Global Bone Regeneration Material Market Report by Region

 

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa